AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,069,000 | -32.4% | 25,623 | -14.4% | 0.00% | -50.0% |
| Q3 2016 | $1,581,000 | +62.8% | 29,935 | +29.2% | 0.00% | +100.0% |
| Q2 2016 | $971,000 | +142.8% | 23,176 | +135.2% | 0.00% | 0.0% |
| Q1 2016 | $400,000 | -51.0% | 9,853 | -21.6% | 0.00% | 0.0% |
| Q4 2015 | $816,000 | -7.4% | 12,567 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $881,000 | -44.8% | 12,487 | -13.1% | 0.00% | -50.0% |
| Q2 2015 | $1,597,000 | -73.4% | 14,368 | -77.4% | 0.00% | -75.0% |
| Q1 2015 | $6,008,000 | -14.5% | 63,716 | +1.6% | 0.01% | -11.1% |
| Q4 2014 | $7,026,000 | +108.4% | 62,710 | +14.1% | 0.01% | +80.0% |
| Q3 2014 | $3,371,000 | +60.9% | 54,939 | +20.2% | 0.01% | +66.7% |
| Q2 2014 | $2,095,000 | +171.4% | 45,714 | +131.8% | 0.00% | +200.0% |
| Q1 2014 | $772,000 | +70.8% | 19,718 | +4.6% | 0.00% | 0.0% |
| Q4 2013 | $452,000 | -14.9% | 18,858 | -0.6% | 0.00% | 0.0% |
| Q3 2013 | $531,000 | – | 18,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |